Press Releases

Myomo Appoints Micah Mitchell as Chief Commercial Officer

By Alex Fusco | July 9, 2018 | 0 Comments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, announced today that Micah Mitchell is joining the company as chief commercial officer (CCO), a newly created executive role. The addition of a CCO reflects Myomo’s transition from a controlled introduction of its proprietary MyoPro product line to expansion of…

Research Team Presents Promising Preliminary Results from TBI Study Using Myomo’s MyoPro

By Alex Fusco | June 27, 2018 | 0 Comments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Researchers from the Northwestern University Prosthetics-Orthotics Center (NUPOC) and the Cleveland VA Medical Center have presented promising preliminary case reports from a clinical trial that evaluates the effects of the MyoPro myoelectric arm orthosis (powered brace) from Myomo on traumatic brain injury (TBI) patients at the Cleveland VA Medical Center. Read more.

Myomo Brings MyoPro to Adolescent Patients

By Alex Fusco | June 6, 2018 | 0 Comments

CAMBRIDGE, Mass., June, 6, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company, today announced that its MyoPro myoelectric arm orthosis (powered brace) is now available to adolescent patients with paralyzed or weakened arms. MyoPro is the only lightweight wearable device on the market that can help restore…

Myomo Announces MyoPro Availability in 16 New U.S. Locations

By Alex Fusco | May 24, 2018 | 0 Comments

CAMBRIDGE, Mass., May 24, 2018 – Myomo®, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced agreements with leading orthotics and prosthetics practices to bring MyoPro® availability to 16 new U.S. locations. Read more.

Myomo® Application for Medicare Codes Receives Favorable Preliminary Decision

By Alex Fusco | May 14, 2018 | 0 Comments

CAMBRIDGE, Mass., May 14, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo,” or the “Company”), a wearable medical robotics company, announces that the Centers for Medicare & Medicaid Services (“CMS”) has published a favorable preliminary decision regarding the Company’s application for Healthcare Common Procedure Coding System (HCPCS) “L” codes. Myomo had filed its application in December…

Myomo, Inc. Issues May 2018 Shareholder Letter

By Alex Fusco | May 10, 2018 | 0 Comments

CAMBRIDGE, Mass., May 10, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today issued a letter to shareholders to give an update on first quarter 2018 and ongoing MyoPro® commercial activities. Read more.

Myomo Reports First Quarter 2018 Results

By Alex Fusco | May 9, 2018 | 0 Comments

CAMBRIDGE, Mass., May 9, 2018 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today reports its financial results for the first quarter ended March 31, 2018. Read more.  

Myomo to Report First Quarter 2018 Results on May 9, 2018

By Alex Fusco | May 3, 2018 | 0 Comments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will release its financial results for the first quarter 2018 on Wednesday, May 9, 2018, after the US markets close. Read more.

Myomo Announces Free Screening Days in Over 20 Cities Nationwide

By Alex Fusco | May 2, 2018 | 0 Comments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, announces a nationwide program of free screening days to be held in collaboration with its Centers of Excellence, other orthotics and prosthetics practices and its rehabilitation therapy partners. Read more.

UPDATE – Myomo Reports Fourth Quarter and Year End 2017 Results

By Alex Fusco | March 16, 2018 | 0 Comments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it is updating its previous release that was made on March 7, 2018 to incorporate certain disclosures that are required under the NYSE AMERICAN Company Guide Sections 401(h) and 610(b). Included below are these additional…